The US Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel is scheduled to decide on Ocular Therapeutix’s premarket approval application for the ReSure Sealant in September and may suggest some recommendations. ...
Tags: Ophthalmic Devices, Health
Mobius Therapeutics, an ophthalmic company, has begun commercial shipments of Mitosol (mitomycin for solution) kit for ophthalmic use. Mitosol will provide a new system for delivering a precise dose of its active ingredient, mitomycin-c, ...